Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer.

Journal: Gynecologic oncology
PMID:

Abstract

PURPOSE: We present a large real-world multicentric dataset of ovarian, uterine and cervical oligometastatic lesions treated with SBRT exploring efficacy and clinical outcomes. In addition, an exploratory machine learning analysis was performed.

Authors

  • Gabriella Macchia
    Radiation Oncology Unit, Responsible Research Hospital, Campobasso, Molise, Italy. Electronic address: gabriella.macchia@responsible.hospital.
  • Savino Cilla
    Medical Physics Unit, Gemelli Molise Hospital, Catholic University of Sacred Heart, 86100 Campobasso, Italy.
  • Donato Pezzulla
    Radiation Oncology Unit, Responsible Research Hospital, Campobasso, Molise, Italy.
  • Maura Campitelli
    UOC di Radioterapia, Dipartimento di Scienze Radiologiche, Radioterapiche ed Ematologiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
  • Concetta Laliscia
    Department of Translational Medicine, Division of Radiation Oncology, University of Pisa, Italy.
  • Roberta Lazzari
    Department of Radiotherapy, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Lorena Draghini
    Radiation Oncology Center, S Maria Hospital, Terni, Italy.
  • Andrei Fodor
    Department of Radiation Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Giuseppe R D'Agostino
    Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Center-IRCCS, via Manzoni 56, 20089, Rozzano, Mi, Italy.
  • Donatella Russo
    Radiotherapy Unit, Ospedale "Vito Fazzi", Lecce, Italy.
  • Vittoria Balcet
    UOC Radioterapia, Nuovo Ospedale degli Infermi, Biella, Italy.
  • Martina Ferioli
    Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Lisa Vicenzi
    Radiation Oncology Unit, Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy.
  • Arcangela Raguso
    UOC Radioterapia, Fondazione "Casa Sollievo della Sofferenza", IRCCS, S. Giovanni Rotondo, Foggia, Italy.
  • Vanessa Di Cataldo
    IFCA Radiotherapy and Medical Physics Unit, Via del Pergolino, 1, 50139 Florence, Italy.
  • Elisabetta Perrucci
    Radiation Oncology Section, Perugia General Hospital, Perugia, Italy.
  • Simona Borghesi
    Radiation Oncology Unit of Arezzo-Valdarno, Azienda USL Toscana sud est, Arezzo, Toscana, Italy.
  • Edy Ippolito
    Department of Radiation Oncology, Campus Bio-Medico University, Roma, Italy.
  • Piercarlo Gentile
    Radiation Oncology Unit, UPMC Hillman Cancer Center San Pietro FBF, Roma, Italy.
  • Vitaliana De Sanctis
    Radiotherapy Oncology, Department of Medicine and Surgery and Translational Medicine, Sapienza University of Rome, S. Andrea Hospital, Roma, Italy.
  • Francesca Titone
    Department of Radiation Oncology, University Hospital Udine, Italy.
  • Clelia Teresa Delle Curti
    Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133 Milan, Italy.
  • Alessandra Huscher
    Fondazione Poliambulanza, U.O. di Radioterapia Oncologica "Guido Berlucchi", Brescia, Italy.
  • Maria Antonietta Gambacorta
    Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy.
  • Gabriella Ferrandina
    Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.
  • Alessio G Morganti
    Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Francesco Deodato
    Radiation Oncology Unit, Responsible Research Hospital, Campobasso, Molise, Italy; Istituto di Radiologia, Università Cattolica del Sacro Cuore Roma, Italy.